Cargando…
Can hepatocellular carcinoma recurrence be prevented after liver transplantation?
Autor principal: | Kim, Jong Man |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524073/ https://www.ncbi.nlm.nih.gov/pubmed/34551504 http://dx.doi.org/10.3350/cmh.2021.0276 |
Ejemplares similares
-
Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation
por: Kim, Bo Hyun, et al.
Publicado: (2018) -
Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review
por: Kim, Sang Jin, et al.
Publicado: (2022) -
Risk factors for poor survival after recurrence of hepatocellular carcinoma after liver transplantation
por: Kim, Minjeong, et al.
Publicado: (2021) -
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation
por: Lee, Okjoo, et al.
Publicado: (2022) -
Hepatocellular recurrence after orthotopic liver transplantation: Is combination of α-fetoprotein and glypican-3 a reliable marker?: Hepatocellular recurrence after orthotopic liver trasplantation
por: Hashemi, Mohammad, et al.
Publicado: (2011)